Drug Trial Radar · NCT00061594
A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration
Last checked: Nov 20, 2026Latest source record: Mar 19, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
426
Actual
Start
May 2003
Primary completion
Not stated
Study completion Sep 2006
Sponsor
- Lead sponsor
- Genentech, Inc.Roche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- May 30, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase III, multicenter, randomized, double-masked, active treatment-controlled study of intravitreally administered ranibizumab compared with verteporfin (Visudyne) photodynamic therapy (PDT) in treating subfoveal neovascular mascular degeneration.
Conditions
- Macular Degeneration
Interventions
rhuFab V2 (ranibizumab)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
82 sites in 6 countries. Site status is shown where the registry gives one.
Retina Centers, P.C.
Tucson, Arizona
University of Arizona
Tucson, Arizona
Retina-Vitreous Associates Medical Group
Beverly Hills, California
UC Irvine
Irvine, California
Doheny Eye Institute
Los Angeles, California
California Vitreoretinal Research Center
Menlo Park, California
No. California Retina-Vitreous Associates
Mountain View, California
UCSF School of Medicine
San Francisco, California
Danbury Eye Physicians & Surgeons
Danbury, Connecticut
New England Retina Associates
Hamden, Connecticut
Florida Retina Institute
Daytona Beach, Florida
Retina Vitreous Consultants
Fort Lauderdale, Florida
Retina Consultants of Southwest Florida
Fort Myers, Florida
Retina Health Center
Fort Myers, Florida
Retina Associates of South Florida
Margate, Florida
Bascom Palmer Eye Institute
Miami, Florida
Central Florida Retina
Orlando, Florida
Retina Care Specialists
Palm Beach Gardens, Florida
Bascom Palmer Eye Institute
Palm Beach Gardens, Florida
Ophthalmic Consultants
Sarasota, Florida
Southern Vitreoretinal Associates PA
Tallahassee, Florida
University of South Florida
Tampa, Florida
Emory University
Atlanta, Georgia
Medical College of Georgia
Augusta, Georgia
Thomas A. Ciulla, MD, PC
Indianapolis, Indiana
University of Kansas Medical Center
Kansas City, Kansas
Retina Associates PC
Annapolis, Maryland
New England Eye Center
Boston, Massachusetts
Center for Eye Research
Boston, Massachusetts
New England Retina Consultants
West Springfield, Massachusetts
University of Michigan
Ann Arbor, Michigan
Associated Retinal Consultants
Grand Rapids, Michigan
Associated Retinal Consultants, P.C.
Royal Oak, Michigan
Retina Consultants of Michigan
Southfield, Michigan
Retina Associates of St. Louis
Florissant, Missouri
St. Louis University Eye Institute
St Louis, Missouri
Delaware Valley Retina Associates
Lawrenceville, New Jersey
Lions Eye Institute
Albany, New York
Ophthalmic Consultants of Long Island
Rockville Centre, New York
Western Carolina Retinal Associates, PA
Asheville, North Carolina
Showing 40 of 82 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.